Palatinose for enhancing dietary supplement and pharmaceutical delivery
Abstract
The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a sports performance product, a weight loss product or a meal replacement product. The present invention is also directed to a method of increasing the absorption of a compound into the bloodstream, cells and tissue comprising administering palatinose, or a derivative thereof, in combination with the compound. The present invention also relates to a diluent for parenteral compounds. The diluent comprises palatinose or a derivative thereof. Another aspect of the present invention is directed to a method of decreasing the recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose, or a derivative thereof, to the mammal. The present invention is further directed to a method of supplying a compound to a diabetic patient, burn victim patient or trauma victim patient. The method comprises administering palatinose, or a derivative thereof, in combination with the compound.
Claims
exact text as granted — not AI-modified1 - 27 . (canceled)
28 . A method of decreasing recovery time to pre-performance levels of total adenosine triphosphate (ATP) levels in a mammal comprising administering palatinose and one or more of creatine, a creatine salt, a creatine ester and a creatine chelate to the mammal.
29 . A method of increasing the absorption of one or more of creatine, a creatine salt, a creatine ester and a creatine chelate in a mammal comprising administering to the mammal palatinose and one or more of creatine, a creatine salt, a creatine ester and a creatine chelate.
30 . The method of claim 28 , wherein administering palatinose and one or more of creatine, a creatine salt, a creatine ester and a creatine chelate also reduces fatigue associated with athletic activity of the mammal.
31 . The method of claim 28 or 29 , wherein the palatinose and one or more of creatine, a creatine salt, a creatine ester and a creatine chelate are administered in a solution with water or saline.
32 . The method of claim 28 or 29 , further comprising administering a dietary supplement or nutrient along with said palatinose and one or more of creatine, a creatine salt, a creatine ester and a creatine chelate.
33 . The method of claim 32 wherein palatinose and/or one or more of creatine, a creatine salt, a creatine ester and a creatine chelate are added to a dietary supplement or nutrient formulation prior to administration.
34 . The method of claim 31 , wherein the concentration of palatinose in the solution is between approximately 1% and approximately 85%.
35 . The method of claim 31 , wherein the concentration of palatinose in the solution is between about 10% and about 50%.
36 . The method of claim 33 , wherein the palatinose is added to the dietary supplement or nutrient formulation prior to administration and wherein the concentration of palatinose in the dietary supplement or nutrient formulation is between approximately 1% and approximately 85%.
37 . The method of claim 33 , wherein the palatinose is added to the dietary supplement or nutrient formulation prior to administration and wherein the concentration of palatinose in the dietary supplement or nutrient formulation is between about 10% and about 50%.
38 . The method of claim 28 or 29 , wherein the palatinose and one or more of creatine, a creatine salt, a creatine ester and a creatine chelate are administered orally or parenterally.
39 . The method of claim 28 or 29 , wherein the palatinose is administered in a dose between about 0.5 grams and about 200 grams.
40 . A method of increasing the absorption of a compound into the bloodstream, cells or tissue of a mammal comprising: administering palatinose and one or more of creatine, a creatine salt, a creatine ester and a creatine chelate in combination with the compound to the mammal.
41 . The method of claim 40 , wherein the compound is a dietary supplement or a nutrient.
42 . A dietary supplement comprising palatinose and one or more vitamins.
43 . The dietary supplement of claim 42 , further comprising one or more compounds selected from the group consisting of a sugar, a stimulant, an amino acid, and a mineral.
44 . A dietary supplement comprising palatinose and one or more minerals.
45 . The dietary supplement of claim 44 , further comprising one or more compounds selected from the group consisting of a sugar, a stimulant, an amino acid, and a vitamin.Join the waitlist — get patent alerts
Track US2009281055A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.